Detalles de la búsqueda
1.
Long-term overall- and progression-free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non-Hodgkin lymphoma.
Br J Haematol
; 185(4): 670-678, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30820940
2.
Encouraging activity for R-CHOP in advanced stage nodular lymphocyte-predominant Hodgkin lymphoma.
Blood
; 130(4): 472-477, 2017 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28522441
3.
Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma.
Cancer
; 124(12): 2561-2569, 2018 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29723393
4.
Impact of the timing of hepatitis B virus identification and anti-hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapy.
Cancer
; 123(17): 3367-3376, 2017 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28518219
5.
High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R-FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study.
Br J Haematol
; 177(2): 263-270, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28340281
6.
Rituximab plus hyper-CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson Cancer Center.
Br J Haematol
; 172(1): 80-8, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26648336
7.
Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum ß2-microglobulin level in patients with diffuse large b-cell lymphoma: a new prognostic model.
Br J Haematol
; 175(2): 290-299, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27448187
8.
"Ordnung und Organisation". Interview zur Historiographie der Biologie mit Hans-Jörg Rheinberger und Peter McLaughlin*.
Ber Wiss
; 44(3): 267-280, 2021 09.
Artículo
en Alemán
| MEDLINE | ID: mdl-34467540
9.
Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomas.
Br J Haematol
; 169(6): 814-23, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25828695
10.
Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-cell lymphoma.
Br J Haematol
; 171(4): 509-16, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26260306
11.
Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial.
Lancet Oncol
; 15(12): 1311-8, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25439689
12.
Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma.
Br J Haematol
; 167(2): 177-84, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25039868
13.
90Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky disease.
Br J Haematol
; 167(2): 207-13, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25040450
14.
Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma.
Blood
; 119(18): 4123-8, 2012 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-22371887
15.
Neuroscience explanations really do satisfy: A systematic review and meta-analysis of the seductive allure of neuroscience.
Public Underst Sci
; 33(3): 290-307, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37906516
16.
Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo(®) ) substituted for non-liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressive non-Hodgkin lymphomas.
Br J Haematol
; 162(5): 631-8, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23802738
17.
Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma.
Br J Haematol
; 163(5): 611-20, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24117234
18.
Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial.
Lancet Oncol
; 13(7): 716-23, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22677155
19.
Reports of the death of CB1 antagonists have been greatly exaggerated: recent preclinical findings predict improved safety in the treatment of obesity.
Behav Pharmacol
; 23(5-6): 537-50, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22743603
20.
Investigation of Ionization Potential in Quantum Dots Using the Stratified Stochastic Enumeration of Molecular Orbitals Method.
J Chem Theory Comput
; 18(10): 5920-5935, 2022 Oct 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36136935